HABIBIZAD NAZILA (See Remarks) received a stock award from GLOBAL BLOOD THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/6/2022ACC: 0000899243-22-030480
Officer· See Remarks
Since Mar 2022
-928.00
Net shares
Net seller
$91.5K
Total sold
0
Open market trades
0B · 0S
6
Total transactions
4.29K acquired · 5.22K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+414.00
Price / share
$25.37
Trade value
$10.50K
% of position
4.6%
8/31/2022
8.92K→9.33K
Common Stock
Direct
Shares
+1.67K
Price / share
—
Trade value
—
% of position
17.9%
9/1/2022
9.33K→11K
Common Stock
Direct
Shares
+2.21K
Price / share
—
Trade value
—
% of position
20.1%
9/1/2022
11K→13.21K
Common Stock
Direct
Shares
−1.34K
Price / share
$68.15
Trade value
$91.46K
% of position
10.2%
9/1/2022
13.21K→11.87K
Total
Net shares
+2.95K
Net value
-$80.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2022 | A · Award | +414.00 | $25.37 | $10.50K | 4.6% | 8.92K | 9.33K |
| Common Stock Direct | 9/1/2022 | M · Option Exercise | +1.67K | — | — | 17.9% | 9.33K | 11K |
| Common Stock Direct | 9/1/2022 | M · Option Exercise | +2.21K | — | — | 20.1% | 11K | 13.21K |
| Common Stock Direct | 9/1/2022 | F · Tax Withholding | −1.34K | $68.15 | $91.46K | 10.2% | 13.21K | 11.87K |
| Total | +2.95K | -$80.95K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
1.67K shares
Shares
−1.67K
Strike price
Held after
8.35K
Exercisable
—
9/1/2022
Restricted Stock Units
Direct
Converts to
Common Stock
2.21K shares
Shares
−2.21K
Strike price
Held after
15.46K
Exercisable
—
9/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock1.67K shares | 9/1/2022 | M · Option Exercise | −1.67K | — | 8.35K | |
| Restricted Stock Units Direct | Common Stock2.21K shares | 9/1/2022 | M · Option Exercise | −2.21K | — | 15.46K |